Evidence map›Paper›PMID 42790259›Full record

ArticleFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association2026

Corrigendum to: "Letter to Editor "Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs": Important concerns on the validity of this article" [Food Chem. Toxicol. (2023), 178, 113897. https://doi.org/10.1016/j.fct.2023.113897].

Jérôme Barrière, Fabrice Frank, Lonni Besancon, Alexander Samuel, Véronique Saada, Eric Billy, Abraham Al-Ahmad, Nans Florens, Barbara Seitz-Polski, Jacques Robert

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Jérôme BarrièreMedical Oncology Department, Polyclinique Saint-Jean, Cagnes-sur-Mer, France.
Fabrice FrankEssaouira, Morocco.
Lonni BesanconMedia and Information Technology, Linköping University, Norrköping, Sweden.
Alexander SamuelGrasse, France.
Véronique SaadaBiopathology Department, Gustave Roussy Anticancer Canter, Villejuif, France.
Eric BillyStrasbourg, France.
Abraham Al-AhmadDepartment of Pharmaceutical Sciences, Texas Tech University Health Sciences Center - Jerry H. Hodge School of Pharmacy, Amarillo, TX, United States.
Nans FlorensDepartment of Nephrology, Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.
Barbara Seitz-PolskiDepartment of Immunology & UR2CA, Côte d'Azur University, CHU Nice, 151 Route Saint-Antoine de Ginestière, Nice, 06200, France.
Jacques RobertUniversité de Bordeaux, INSERM Unité 1312, 229 Cours de l'Argonne, Bordeaux, 33076, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.